| Overview |
| bsm-90074R |
| CD99 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CD99 |
| 15-70/185 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4267 |
| P14209 |
| CD99; CD99 Molecule (Xg Blood Group); CD99 Antigen; MIC2; Antigen Identified By Monoclonal Antibodies 12E7 F21 And O13; T-Cell Surface Glycoprotein E2; E2 Antigen; MIC2X; MIC2Y; Antigen Identified By Monoclonal 12E7 Y Homolog; MIC2 (Monoclonal Antibody 12E7); Cell Surface Antigen HBA-71; Cell Surface Antigen 12E7; Cell Surface Antigen O13; Surface Antigen MIC2; CD99 Molecule; Protein MIC2; HBA71; MSK5X; 12E7 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz